MXPA05004379A - Inhibidor de la infeccion por el virus del dengue. - Google Patents

Inhibidor de la infeccion por el virus del dengue.

Info

Publication number
MXPA05004379A
MXPA05004379A MXPA05004379A MXPA05004379A MXPA05004379A MX PA05004379 A MXPA05004379 A MX PA05004379A MX PA05004379 A MXPA05004379 A MX PA05004379A MX PA05004379 A MXPA05004379 A MX PA05004379A MX PA05004379 A MXPA05004379 A MX PA05004379A
Authority
MX
Mexico
Prior art keywords
dengue virus
virus infection
infection inhibitor
inhibitor
infection
Prior art date
Application number
MXPA05004379A
Other languages
English (en)
Inventor
Ilpal Jwa
Original Assignee
Japan Science & Tech Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science & Tech Agency filed Critical Japan Science & Tech Agency
Publication of MXPA05004379A publication Critical patent/MXPA05004379A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se provee un inhibidor de la infeccion del virus del dengue, como un farmaco que inhibe efectivamente la infeccion con el virus del dengue, que se caracteriza por contener, como el ingrediente activo, por lo menos una molecula de carbohidratos que tiene como un constituyente esencial una cadena de oligosacaridos representada por la siguiente formula (I): Hex1NAc(1-3Hex2(1-4Hex1(1-(I) (en donde Hex1 y Hex2 representan una hexosa).
MXPA05004379A 2002-10-22 2003-10-22 Inhibidor de la infeccion por el virus del dengue. MXPA05004379A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002307232 2002-10-22
PCT/JP2003/013486 WO2004037272A1 (ja) 2002-10-22 2003-10-22 デング熱ウィルス感染阻害剤

Publications (1)

Publication Number Publication Date
MXPA05004379A true MXPA05004379A (es) 2005-11-23

Family

ID=32170933

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05004379A MXPA05004379A (es) 2002-10-22 2003-10-22 Inhibidor de la infeccion por el virus del dengue.

Country Status (7)

Country Link
US (1) US20060104985A1 (es)
EP (1) EP1563840A1 (es)
JP (1) JPWO2004037272A1 (es)
CN (1) CN1705488A (es)
BR (1) BR0314911A (es)
MX (1) MXPA05004379A (es)
WO (1) WO2004037272A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2349257B1 (en) 2008-06-17 2013-11-27 Universidade Federal de Minas Gerais-UFMG Use of paf receptor for treating infections caused by flaviviridae

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
JPH0725689B2 (ja) * 1986-10-07 1995-03-22 中外製薬株式会社 顆粒球コロニ−刺激因子を含有する徐放性製剤
ATE107033T1 (de) * 1987-11-20 1994-06-15 Abbott Lab Nachweis von tumorassozierten anzeigern in biologischen flüssigkeiten.
JPH0687061B2 (ja) * 1988-04-12 1994-11-02 ダイナボット株式会社 糖転移酵素活性の免疫学的測定方法
JPH03115863A (ja) * 1990-09-10 1991-05-16 Dainabotsuto Kk 免疫学的測定法による糖脂質の定量方法
US6197568B1 (en) * 1997-07-29 2001-03-06 The Regents Of The University Of Michigan Method and compositions for isolation, diagnosis and treatment of polyanion-binding microorganisms

Also Published As

Publication number Publication date
CN1705488A (zh) 2005-12-07
BR0314911A (pt) 2005-09-27
JPWO2004037272A1 (ja) 2006-02-23
EP1563840A1 (en) 2005-08-17
US20060104985A1 (en) 2006-05-18
WO2004037272A1 (ja) 2004-05-06

Similar Documents

Publication Publication Date Title
NO20034660D0 (no) Spiropyrazolforbindelser
UA94065C2 (en) Dihydropseudoerythromycin derivatives
ATE373005T1 (de) Thienopyrrole als antivirale mittel
NO20052787L (no) N-alkyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
BRPI0415773A (pt) derivados de indolinona e sua aplicação no tratamento de estados de doença tais como cáncer
AR038323A1 (es) Mezclas insecticidas sinergicas
IL182315A0 (en) 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection
EA200801144A1 (ru) Полициклическое карбамоилпиридоновое производное, обладающее ингибиторной активностью в отношении интегразы вич
DE60323756D1 (de) Pharmazeutisch aktive oligosaccharid-conjugate
NO20044807L (no) Heratitt C virus inhibitorer
EA200401494A1 (ru) Бактерицидные пиримидины или триазины для профилактики передачи вич половым путём
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
AR039701A1 (es) Combinaciones de compuestos activos fungicidas
NZ596107A (en) Antiviral compounds and methods
BRPI0412851A (pt) benzamidazóis de n-metila-substituìdos
ATE485049T1 (de) Physiologisch aktive zusammensetzung gegen diabetes
NO20052788L (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
UA95095C2 (en) 11 beta-hydroxyandrosta-1,4-diene-3-ones
MXPA05002307A (es) Composiciones antimicrobianas.
MX2007005336A (es) Analgesicos.
CO5560555A2 (es) Cristales de derivado de hidroxinorefedrina
MX2009001578A (es) Lactamas terapeuticas.
BR0111729A (pt) 1-aril-4-oxo-1,4-dihidro-3-quinolinacarboxamidas como agentes antivirais
BRPI0317188A2 (pt) Novo derivado de 2,4-diamino-1,3,5-triazina
MXPA05004379A (es) Inhibidor de la infeccion por el virus del dengue.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal